Exocrine pancreatic insufficiency in a patient with regionally recurrent cutaneous squamous cell carcinoma undergoing treatment with cemiplimab.
1/5 보강
Cutaneous squamous cell carcinoma (cSCC) is a common non-melanoma skin cancer with low rates of local recurrence or distant metastasis except for tumours with high-risk features, which result in signi
APA
Albuja Altamirano MF, O'Loughlin L, et al. (2025). Exocrine pancreatic insufficiency in a patient with regionally recurrent cutaneous squamous cell carcinoma undergoing treatment with cemiplimab.. BMJ case reports, 18(11). https://doi.org/10.1136/bcr-2025-267746
MLA
Albuja Altamirano MF, et al.. "Exocrine pancreatic insufficiency in a patient with regionally recurrent cutaneous squamous cell carcinoma undergoing treatment with cemiplimab.." BMJ case reports, vol. 18, no. 11, 2025.
PMID
41298244 ↗
Abstract 한글 요약
Cutaneous squamous cell carcinoma (cSCC) is a common non-melanoma skin cancer with low rates of local recurrence or distant metastasis except for tumours with high-risk features, which result in significantly decreased rates of overall survival compared with low-risk lesions. Immune checkpoint inhibitors (ICIs) (cemiplimab and pembrolizumab) represent a promising therapeutic option for cases of unresectable or metastatic disease, but despite their benefit, they pose a risk of immune-related adverse effects. We present the case of a patient with recurrent cSCC on cemiplimab, who developed exocrine pancreatic insufficiency induced by ICI. She presented with symptoms related to malabsorption that improved with pancrelipase but did not exhibit hyperglycaemia, contrary to what is commonly described with ICI-exocrine pancreatic insufficiency (EPI). This case highlights the importance of recognising ICI-EPI as a potential adverse effect in patients with malabsorption while on ICI and to risk-stratify patients with high-risk cSCC for prompt treatment and improved outcomes.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Female
- Humans
- Antibodies
- Monoclonal
- Humanized
- Antineoplastic Agents
- Immunological
- Carcinoma
- Squamous Cell
- Exocrine Pancreatic Insufficiency
- Immune Checkpoint Inhibitors
- Neoplasm Recurrence
- Local
- Pancrelipase
- Skin Neoplasms
- Drugs: endocrine system
- Head and neck cancer
- Malabsorption
- Malignant disease and immunosuppression
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.